https://www.ophthalmologytimes.com/view/inverted-ilm-flap-technique-improves-outcomes-macular-hole-surgery 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/subretinal-therapy-offers-promise-lighter-treatment-burden-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/experts-weigh-retina-subspecialty-day 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/drs-wykoff-kim-and-spaide-summarize-day-two-retina-subspecialty-day-aao-2017 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/uveitis-updates-retina-subspecialty-day-2017 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/octa-future-bright-fast-and-wide-rop 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/tumor-targeted-therapy-changing-game-choroidal-melanoma 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/nlp-status-after-open-globe-injury-not-always-permanent 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/octa-providing-two-one-imaging-and-practical-value 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/highlights-day-2-retina-subspecialty-day-2017 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/retina-experts-discuss-highlights-2017-live-aao 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/schepens-lecturer-traces-advent-evolution-ophthalmic-trials 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/sustained-drug-delivery-technologies-shape-promising-future 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/gene-therapy-benefits-retinal-dystrophies-persist-through-trial 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/highlights-day-1-retina-subspecialty-day-2017 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/phase-iv-study-shows-improved-dme-outcomes-fluocinolone-acetonide-implant-0 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/positive-and-negative-data-highlight-subspecialty-day 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/hypersonic-vitrector-holds-potential-multiple-benefits 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/outcomes-differ-trials-real-world-anti-vegf-therapy-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/novel-dme-treatment-derives-multimodal-activity 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/investigational-trials-target-vegfangiopoietin2-inhibition 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/povidone-iodine-reapplication-protocol-preventing-endophthalmitis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/retina-subspecialty-day-offers-bit-everything 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/gene-therapies-and-controversial-topics 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/inaugural-retina-research-scholar-program-be-major-highlight-aao-2017 2020-12-20 0.50 https://www.ophthalmologytimes.com/view/intravitreal-brimonidine-holds-promise-slowing-ga-growth 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/novel-brolucizumab-fosters-real-world-alternative-namd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/iol-telescope-may-improve-vision-patients-advanced-maculopathies 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/study-finds-yag-laser-vitreolysis-may-be-option-floaters 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/alg-1001-turning-machinery-angiogenesis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/aflibercept-helps-me-patients-dr-after-cataract-surgery 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ao-imaging-offers-novel-data-understanding-retinal-disease 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/role-corticosteroids-uncertain-amd-management 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/octa-system-offers-exquisite-views 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/tracking-growth-ultra-widefield-imaging-disease-management 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ultra-widefield-camera-captures-images-macula-far-periphery 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/insights-preventing-trd-pdr-patients-after-avastin-vitrectomy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/27-gauge-presents-new-paradigm-intraocular-precision-vitrectomy 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/temporary-scleral-buckling-offers-advantages-retinal-detachment 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/reactivating-cones-possibility-addressing-rp 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/how-achieve-calm-stress-free-or 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/intraoperative-oct-faces-prime-time-added-technology-needed 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/research-offers-insights-success-macular-hole-surgery 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/suprachoroidal-hemorrhage-management-centers-minimalist-techniques 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/exploring-sirolimus-potential-alternative-therapy-persistent-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/priming-syringe-injection-associated-lower-frequency-silicone-oil-droplets 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/shrm-characteristics-impact-visual-acuity-wet-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/dna-based-analysis-identifies-risk-factor-metastasis-uveal-melanoma 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/persistence-key-when-promoting-surgical-innovations 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/unmasking-retinal-structure-function-x-linked-retinoschisis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/dye-aai-fruit-safe-effective-use-during-chromovitrectomy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/bl-next-generation-surgical-platform-features-advanced-retina-capabilities 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/paracentral-retinotomy-facilitates-closure-large-resistant-macular-hole 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/laser-retains-limited-role-management-rvo-related-me 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/octa-brings-understanding-managing-diabetic-eye-disease 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/assessing-impact-flacs-surgical-outcomes 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/scleral-buckle-technique-using-ppv-laser-photocoagulation 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/anti-angiogenic-agent-platform-planned-human-trial 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/new-therapies-uveal-melanoma-target-radiation-toxicity-metastatic-risk 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/retinectomy-under-air-solution-retina-reattachment 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/reduced-risk-cnv-after-sdm-laser-retinal-protective-therapy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/diagnosing-and-treating-mactel-degenerative-retinal-disease 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/vma-associated-poor-outcomes-anti-vegf-treated-patients 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/oct-imaging-yields-better-visualization 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/5-observations-about-corticosteroids-dme-treatment 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/how-wide-field-ss-oct-expands-spectrum-normal-peripheral-retina 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/new-hypersonic-vitrector-introduces-concept-vitreous-liquefaction 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/how-adaptive-optics-will-change-retinal-imaging 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/systemic-safety-anti-vegf-treatment-rop-mandates-further-study 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/novel-therapies-abound-pipeline 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/inhibition-plgf-shows-additional-features-compared-vegf-inhibition 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/real-world-outcomes-aflibercept-better-treatment-nave-patients 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/multifunctional-oct-system-approval-simplifies-imaging 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/sirolimus-shows-promise-posterior-segment-non-infectious-uveitis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ebola-may-leave-retinal-scar 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/anti-pdgf-inhibitor-development-continues-despite-negative-results 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/5-year-catt-analysis-finds-anti-vegf-drugs-long-term-amd-therapy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/selective-techniques-revolutionize-treatment-retinoblastoma 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/targeted-vitreoretinal-lymphoma-therapies-mimic-other-approaches 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/tapping-gene-therapy-potential-inherited-retinal-diseases 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/fda-approves-tocilizumab-first-therapy-gca 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/endoillumination-growth-amplifies-tissue-visualization 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/pros-and-cons-compounded-pharmaceuticals 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/new-and-different-therapies-emerging-through-uveitis-pipeline 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/nice-recommends-dexamethasone-adalimumab-uveitis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/access-costs-bevacizumab-key-factors-dme-therapy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/data-clearly-demonstrates-bevacizumabs-inferiority-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/vitrectomy-beats-scleral-buckling-rhegmatogenous-retinal-detachment-study 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/limiting-inflammation-may-decrease-nerve-damage-preserve-cell-function 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/trials-making-strides-identifying-rop-risk-factors-predictive-models 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/darpin-molecule-prolongs-anti-vegf-activity-namd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/no-one-imaging-tool-fits-all-identifying-amd-lesions 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/retina-surgeons-amd-regimen-center-medicare-fraud-case 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/treating-rop-laser-associated-high-success-rate-retinopathy-prematurity 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/treating-rop-substantial-benefits-make-anti-vegf-preferred-zone-i-disease 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/genetic-testing-initiative-inherited-retinal-diseases-shows-great-promise 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/aflibercept-rivals-laser-diabetic-retinopathy 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/new-molecule-enhances-effect-anti-vegf-therapy-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/insights-anti-vegf-pivotal-dme-trials 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/endocryotherapy-shows-potential-hemangioblastoma 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/nrtis-hold-promise-preventing-or-treating-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/sakura-program-reinforces-efficacy-safety-intravitreal-sirolimus 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/adalimumab-promising-treating-jia-associated-uveitis-study-finds 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/year-2-protocol-t-data-paints-different-scenario-year-1 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/dave-study-found-little-benefit-anti-vegfprp-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ilm-removal-increases-ease-safety-subretinal-injections 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/new-technology-takes-invisibility-cloak-retinal-imaging 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ilm-peeling-retinal-staining-aids-macular-hole-closure 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/4-pattern-recognition-skills-are-relevant-clinic 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/how-do-retinal-specialists-feel-about-oct-angiography 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/investigational-wet-amd-therapies-aim-innovative-targets 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/failed-cell-therapy-study-offers-positives-raises-new-questions 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/novel-anti-vegf-agent-shows-promise-prolonged-dme-activity 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/sustained-release-corticosteroid-implant-improves-slows-progression-diabetic-retinopathy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/expanded-line-27-gauge-instruments-advantageous 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/laser-still-useful-diabetic-eye-disease-tool-anti-vegf-era 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/personalizing-therapy-retinal-disease 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/benefits-certain-risks-less-clear-anti-vegf-rop 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/flanged-fixation-secures-iol-haptics-within-sclera 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/new-insights-pachychoroid-spectrum 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/epiretinal-prosthesis-life-changing-some-rp-patients 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/effective-drug-management-pvr-remains-unfulfilled-goal 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/strategies-macular-hole-recurrence-after-small-gauge-vitrectomy 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/research-limited-role-combination-therapy-crvo-related-me 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/trex-amd-trial-finds-visual-gains-treat-and-extend-vs-monthly 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/treatment-geographic-atrophy-lacks-efficacy-phase-2-study 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/nailing-intravitreal-implant-injections 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/new-concepts-about-macular-edema-emerge-modern-imaging-studies 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/transplantable-3-d-retinas 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/enhancing-retinal-surgery-27-gauge-instrumentation 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/findings-reaffirm-ocriplasmin-success-symptomatic-vma-over-long-term 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/data-support-adding-suprachoroidal-injection-anti-vegf-rvo 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/system-offers-advanced-capabilities-oct-octa 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/seeing-reality-artificial-vision 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/introducing-modern-retina 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ideal-disease-control-leads-better-namd-outcomes 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/treat-and-extend-may-lead-better-amd-results 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/computer-based-image-analysis-promising-rop 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/paradigm-shifting-ilm-peeling-prone-position-after-vitrectomy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/new-biomarker-may-predict-treatment-response-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/6-things-pcps-should-know-about-diabetic-vision-loss 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/retina-geography-not-associated-cognitive-decline 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/lower-treatment-burden-aflibercept-crvos 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/new-study-affirms-promise-anti-integrin-drug-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/real-world-uk-ranibizumab-dmo-outcomes-match-trials 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/how-genes-may-influence-anti-vegf-treatment 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/future-dme-resting-new-mechanisms-action 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/year-review-surgical-retina 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/2016-brings-retinal-imaging-starring-role 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/introducing-3-d-oct-live-surgery 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/drug-therapies-moving-beyond-anti-vegfs 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/researchers-reject-vitamin-d-role-macular-degeneration 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/top-ophthalmic-challenges-2017 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/exploring-effects-anti-vegf-therapy-retinal-diseases 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/choosing-right-treatment-proliferative-diabetic-retinopathy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/long-term-aflibercept-effective-namd-after-other-anti-vegf-therapies-failed 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/topical-treatment-neovascular-amd-within-sight 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/adalimumab-effective-not-cure-uveitis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/inverted-flap-technique-yields-high-success-rates 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/keratoprosthesis-implantation-potentially-helpful-tricky 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/agent-gene-therapy-promising-retinal-dystrophy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/lower-treatment-burden-earlier-administration-anti-vegf-therapy-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/what-ophthalmologists-need-know-about-diabetes 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/heads-vitreoretinal-surgery-system-debuts 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/sustained-release-intravitreal-implant-viable-alternative-anti-vegfs-dme-patients 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/retinal-prosthesis-system-ranks-high-safety-performance 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/coin-sized-retina-scanner-targets-improved-diagnosis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/silicone-oil-complications-mostly-manageable 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/exploring-oral-dual-anti-vegfpdgf-inhibitor-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/considering-body-posture-after-macular-hole-surgery 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/anti-vegf-induces-regression-diabetic-retinopathy-high-risk-populace 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/catt-follow-explores-long-term-outcomes-anti-vegf-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/current-generation-equipment-brings-benefits-27-gauge-vitrectomy-more-eyes 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/handheld-device-offers-early-screening-amblyopia 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/systemic-implications-highlighted-retinal-tumor-findings 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/inexpensive-laser-pointers-threat-eyesight 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/targeting-survival-pathway-future-therapeutics-diabetic-retinopathy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/visual-cycle-metabolites-cause-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/researchers-glimpse-parkinsons-rats-eyes 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/biosimilar-ranibizumab-clears-hurdles-india 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/long-term-efficacy-dme-fewer-injections-yes-please 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/new-telemonitoring-device-makes-impact-detecting-cnv 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/why-patience-key-suprachoroidal-hemorrhages-and-detachments 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/sd-oct-enhanced-visualization-earlier-disease-process 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/wide-field-imaging-big-picture-quick-accurate-diagnosis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/dry-amd-therapy-evolves-photobiomodulation 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/collaboration-needs-exist-between-retinal-glaucoma-specialists 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/early-response-anti-vegf-therapy-predictive-longer-term-results 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/gene-based-treatment-provides-sustained-amd-therapy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/identifying-new-forms-infectious-uveitis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/gene-therapy-rpe65-trial-offers-promise-improved-vision 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/sonepcizumab-combination-therapy-may-offer-long-term-visual-acuity-stabilization 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/electroretinography-detects-early-glaucoma-signs 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/differentiating-among-mosquito-borne-forms-uveitis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/does-multispot-photocoagulation-interfere-driving 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/does-quality-life-dme-therapies-have-price 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/diabetic-retinopathy-debate-resurfaces-new-perspectives 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/new-mosaic-retinitis-pigmentosa-mutation-reported 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/tie2-activator-augments-anti-vegf-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/anti-vegf-shows-benefits-cnv-rare-diseases 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/mining-data-anti-vegf-therapy-insights-pcv 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/dme-therapy-plasma-kallikrein-inhibitor-showing-promise 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/launch-retina-world-congress-unites-global-thought-leaders 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/applying-lessons-immune-response-cmv-retinitis-aids 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/retinal-exam-brings-diabetic-retinopathy-screening-primary-care-setting 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/why-naion-remains-ophthalmologists-dilemma 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/importance-macular-degeneration-declining-england-and-wales 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/discover-value-en-face-oct-imaging-retinal-diseases 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ioct-next-paradigm-shift-vitreoretinal-surgery 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ease-ultra-widefield-retinal-imaging-appeals-physicians-patients 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/genetic-mutation-findings-spanish-retinitis-pigmentosa 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/diabetic-retinopathy-and-macular-oedema-increase-spain 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/outer-retinal-layer-thickness-predicts-visual-acuity-diabetic-macular-oedema 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/viral-mediated-gene-therapy-approaches-retinal-degeneration 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/pre-existing-ruptured-posterior-capsule-presents-unique-challenges 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/how-avoid-explosive-silicone-oil-injector-separation 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/new-prevention-and-monitoring-strategies-neovascular-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/innovations-fuel-sustained-drug-delivery-methods-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/study-fluocinolone-acetonide-02-gday-reduced-dr-progression 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/developing-cell-based-therapies-inherited-retinal-disease 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/smartphones-hold-implications-retinal-screening-beyond 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/heads-surgery-current-advantages-debatable-system-offers-opportunities-future 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/virtual-trial-designed-explore-amd-monitoring 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/managing-challenges-giant-retinal-tear-re-attachment 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/fundus-perimetry-may-alter-management-glaucoma 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/imaging-27-gauge-systems-capture-retina-surgeons-focus 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/year-brings-advances-retinal-imaging-screening-and-genedrug-therapies 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/persistent-subfoveal-fluid-following-successful-macular-hole-surgery 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/drcrnet-retinal-treatment-results-take-center-stage-2015 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/diopsys-portable-device-aids-detection-retinal-pathologies 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/diopsys-portable-device-aids-detection-retinal-pathologies-0 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/top-5-retina-news-stories 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/new-treatments-developed-inherited-retinal-diseases 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/surgery-25-and-27-gauge-tools-mostly-similar-minor-variances 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/combination-anti-vegf-navigated-laser-dme-par-monotherapy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/new-blade-design-allows-higher-flow-greater-cut-rates 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/eye-strokes-linked-bigger-risk-cardiovascular-problems 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/bone-marrow-cells-show-promise-degenerative-ischemic-retinal-diseases 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/pars-plana-vitrectomy-makes-paradigm-shift-retinal-surgery-europe 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/nitrosative-oxidative-stress-associated-structural-changes 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/high-res-device-gives-retinal-imaging-facelift 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/suprachoroidal-injection-triamcinolone-acetonide-uveitis-proves-promising 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/real-world-setting-proving-positive-intravitreal-implant-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/trending-now-hottest-surgery-stories-2014 2020-11-14 0.50 https://www.ophthalmologytimes.com/view/improvements-imaging-corneal-biomechanics-take-center-stage 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/drug-delivery-micropump-chronic-retina-disorders 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/study-home-monitoring-device-identifies-new-cnv-faster-less-vision-loss 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/retinal-vein-occlusion-treatment-undergoes-paradigm-shift-pharmacotherapy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/jackson-memorial-lecture-past-present-and-future-outlook-retinoblastoma 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/use-retinal-prosthesis-system-shapes-vision-those-retinitis-pigmentosa 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/grand-rounds-patient-recent-hospitalization-and-decreased-vision-1-month 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/retinal-inflammation-novel-drug-delivery 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/outlook-integrin-peptide-therapy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/fda-clears-nidek-oct-system 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/vitreous-orphan-eye 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/small-gauge-surgery-maximizes-retina-outcomes 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/technology-heralds-retinal-prosthesis-advanced-lasers 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/retina-drug-therapies-ever-evolving 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/combined-steroids-anti-vegfs-show-promise-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/anti-seizure-drug-gets-boxed-warning-eye-damage-risks 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/critical-retinal-development-gene-identified 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/genetic-testing-shows-promise-predicting-amd-progression 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/determining-ocriplasmin-success 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/application-ioct-ophthalmic-surgery-pioneer-18-month-results 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/understanding-genetic-risk-factors-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ultra-widefield-fa-vital-recalcitrant-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/argument-against-subthreshold-laser-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/laser-treatment-necessary-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/whats-next-neovascular-amd-pipeline 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/arvo-2013-sight-set-world-class-science 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/vitreous-history-making 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/jetrea-gets-nice-reimbursement-recommendation 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/unilateral-decreased-vision-2-years 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/retina-summit-precede-arvo 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/optos-gets-510k-microperimetry 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/gene-therapy-trials-progress 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/synthetic-corneal-implant-shows-promise-in-eyes-with-chronic-corneal-oedema 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/training-real-surgeon-input-inside-bvi-facility-experience-hub 2026-06-26 0.50 https://www.ophthalmologytimes.com/view/saudi-cohort-study-finds-jia-drives-most-paediatric-uveitis-cases 2026-07-03 0.50 https://www.ophthalmologytimes.com/view/how-the-ocular-microbiome-may-shape-outcomes-in-keratoplasty 2026-07-02 0.50 https://www.ophthalmologytimes.com/view/phaco-gsl-outperforms-in-acute-angle-closure-glaucoma-over-chronic-cases-2-year-study-finds 2026-07-01 0.50 https://www.ophthalmologytimes.com/view/eudec-2026-ectoine-eye-drops-show-meaningful-symptom-tear-film-improvements-dry-eye-disease 2026-06-29 0.50 https://www.ophthalmologytimes.com/view/lumvoa-gains-us-fda-approval-for-thyroid-eye-disease-with-class-first-broad-label 2026-06-29 0.50 https://www.ophthalmologytimes.com/view/dex-implant-shows-benefit-across-rvo-subgroups-in-real-world-retrospective-study 2026-06-25 0.50 https://www.ophthalmologytimes.com/view/q-a-uveitis-risk-rises-as-immune-checkpoint-inhibitor-use-expands 2026-06-26 0.50 https://www.ophthalmologytimes.com/view/european-dry-eye-society-congress-2026-artelac-complete-dry-eye 2026-06-23 0.50 https://www.ophthalmologytimes.com/view/study-examines-accommodation-after-iris-fixated-phakic-iol-implantation 2026-06-19 0.50 https://www.ophthalmologytimes.com/view/ai-predicted-retinal-function-shows-promise-in-geographic-atrophy 2026-06-18 0.50 https://www.ophthalmologytimes.com/view/faricimab-vabysmo-roche-products-ltd-for-visual-impairment-due-to-macular-oedema-secondary-to-retinal-vein-occlusion-an-educational-supplement 2026-06-22 0.50 https://www.ophthalmologytimes.com/view/demodex-blepharitis-closing-the-diagnostic-gap-to-improve-ocular-surface-health 2026-06-26 0.50 https://www.ophthalmologytimes.com/view/mulling-over-options-for-mitigating-severe-vision-loss-from-diabetes 2026-06-18 0.50 https://www.ophthalmologytimes.com/view/review-highlights-gaps-in-transition-from-paediatric-to-adult-eye-care 2026-06-19 0.50 https://www.ophthalmologytimes.com/view/the-real-cost-of-persistent-epithelial-defects-lessons-from-an-nhs-audit 2026-06-19 0.50 https://www.ophthalmologytimes.com/view/trehalose-hyaluronate-combination-aids-tear-film-after-eyelid-surgery 2026-06-19 0.50 https://www.ophthalmologytimes.com/view/zeiss-reports-early-implantations-of-at-lucia-toric-721p-iol-in-europe 2026-06-18 0.50 https://www.ophthalmologytimes.com/view/beyond-anti-vegf-the-next-wave-in-retinal-therapy 2026-06-16 0.50 https://www.ophthalmologytimes.com/view/time-is-vision-act-fast-after-ocular-chemical-burns 2026-06-16 0.50 https://www.ophthalmologytimes.com/view/study-finds-similar-corneal-biomechanics-in-2-major-glaucoma-types 2026-06-12 0.50 https://www.ophthalmologytimes.com/view/heidelberg-engineering-announces-fda-clearance-for-new-spectralis-software-release 2026-06-15 0.50 https://www.ophthalmologytimes.com/view/phase-3-northstar-trial-launches-for-gildeuretinol-in-stargardt-disease 2026-06-10 0.50 https://www.ophthalmologytimes.com/view/warm-compresses-may-miss-the-mark 2026-06-10 0.50 https://www.ophthalmologytimes.com/view/refractive-surgery-for-myopia-vs-presbyopia-tailoring-the-approach-for-the-individual 2026-06-08 0.50 https://www.ophthalmologytimes.com/view/opuviz-aflibercept-biosimilar-debuts-in-europe-for-retinal-disease-treatment 2026-06-02 0.50 https://www.ophthalmologytimes.com/view/egs-2026-glaucoma-surgery-imaging-and-neuroscience-take-centre-stage-in-brussels 2026-06-02 0.50 https://www.ophthalmologytimes.com/view/allied-health-professional-led-keratoconus-service-shows-safe-outcomes-in-uk-tertiary-centre 2026-05-29 0.50 https://www.ophthalmologytimes.com/view/first-commercial-flight-procedures-performed-as-vialase-begins-european-launch 2026-05-28 0.50 https://www.ophthalmologytimes.com/view/tinlarebant-earns-swiss-orphan-drug-status-for-stargardt-disease 2026-06-02 0.50 https://www.ophthalmologytimes.com/view/bausch-lomb-launches-advanced-dual-port-vitrectomy-cutter-in-europe 2026-05-11 0.50 https://www.ophthalmologytimes.com/view/rethinking-slt-from-pressure-reduction-to-biological-activation 2026-06-02 0.50 https://www.ophthalmologytimes.com/view/detecting-peripheral-retinal-lesions-in-children-with-myopia 2026-06-03 0.50 https://www.ophthalmologytimes.com/view/reframing-eye-health-through-the-lens-of-aging 2026-06-01 0.50 https://www.ophthalmologytimes.com/view/q-a-continuous-ai-severity-scoring-could-transform-amd-monitoring 2026-04-24 0.50 https://www.ophthalmologytimes.com/view/bvi-virtuoso-receives-ce-mark-for-combined-cataract-and-vitreoretinal-surgery 2026-04-21 0.50 https://www.ophthalmologytimes.com/view/spotlight-on-women-s-health 2026-04-16 0.50 https://www.ophthalmologytimes.com/view/the-gene-therapy-shift 2026-04-17 0.50 https://www.ophthalmologytimes.com/view/early-clinical-impressions-of-the-triton2-and-imagenet7-understanding-the-value-of-swept-source-oct-combined-with-high-quality-colour-fundus-imaging 2026-04-15 0.50 https://www.ophthalmologytimes.com/view/physician-perspective-glaucoma-eye-drops-are-here-to-stay 2026-07-06 0.50 https://www.ophthalmologytimes.com/view/paediatric-and-strabismus-care-evolving-tools-emerging-therapies 2026-07-06 0.50 https://www.ophthalmologytimes.com/view/privosegtor-earns-ema-prime-designation-for-optic-neuritis 2026-04-06 0.50 https://www.ophthalmologytimes.com/view/q1-2026-happenings-in-ophthalmology-major-highlights 2026-07-06 0.50 https://www.ophthalmologytimes.com/view/treating-demodex-blepharitis-resource-burden-patient-experience-and-the-path-forward 2026-03-31 0.50 https://www.ophthalmologytimes.com/view/recognizing-demodex-blepharitis-prevalence-diagnosis-and-clinical-impact 2026-03-31 0.50 https://www.ophthalmologytimes.com/view/health-canada-approves-clobetasol-propionate-ophthalmic-suspension-0-05-for-post-cataract-surgery-inflammation-and-pain 2026-03-30 0.50 https://www.ophthalmologytimes.com/view/beyond-complement-inhibition-in-geographic-atrophy-at-cophy-2026 2026-03-21 0.50 https://www.ophthalmologytimes.com/view/cophy-2026-treat-and-extend-in-the-era-of-sustained-drug-delivery 2026-03-21 0.50 https://www.ophthalmologytimes.com/view/cophy-2026-weighing-in-on-the-evidence-on-glp-1-agonists-and-naion 2026-03-20 0.50 https://www.ophthalmologytimes.com/view/debate-discovery-and-the-future-of-ophthalmology-a-preview-of-cophy-2026 2026-03-20 0.50 https://www.ophthalmologytimes.com/view/onl-therapeutics-randomises-first-european-patient-in-phase-2-ga-trial-of-xelafaslatide 2026-03-16 0.50 https://www.ophthalmologytimes.com/view/johnson-johnson-s-tecnis-puresee-edof-iol-receives-regulatory-approval-in-the-us- 2026-03-12 0.50 https://www.ophthalmologytimes.com/view/winterthur-hosts-wos-2026-with-multispecialty-ophthalmology-agenda 2026-03-12 0.50 https://www.ophthalmologytimes.com/view/detecting-glaucoma-pre-vision-loss-ai-indicators-imaging 2026-03-10 0.50 https://www.ophthalmologytimes.com/view/international-glaucoma-symposium-2026-recap-from-ai-to-migs-in-practice 2026-03-11 0.50 https://www.ophthalmologytimes.com/view/wolf-lagreze-oct-use-limitations-potential-diagnosis 2026-03-04 0.50 https://www.ophthalmologytimes.com/view/steffen-hamann-optic-disc-drusen-diagnostic-overlap-imaging-advances 2026-03-03 0.50 https://www.ophthalmologytimes.com/view/workplace-eye-awareness-month-eye-care-clinicians-are-not-exempt-from-safety-procedures 2026-03-03 0.50 https://www.ophthalmologytimes.com/view/eylea-8mg-in-rvo-quasar-clinical-perspectives-video 2026-03-03 0.50 https://www.ophthalmologytimes.com/view/eylea-8mg-in-rvo-snapshot-of-the-64-week-quasar-data 2026-03-03 0.50 https://www.ophthalmologytimes.com/view/bridging-borders-in-ophthalmology-reflections-on-international-medical-training 2026-04-10 0.50 https://www.ophthalmologytimes.com/view/biotech-healthcare-secures-eu-mdr-certification-for-ophthalmic-and-medical-devices 2026-02-18 0.50 https://www.ophthalmologytimes.com/view/eye-pcr-receives-ce-mark-for-fixoflex-endocapsular-device 2026-02-17 0.50 https://www.ophthalmologytimes.com/view/samsung-bioepis-reaches-settlement-agreement-for-eylea-aflibercept-biosimilar 2026-02-16 0.50 https://www.ophthalmologytimes.com/view/international-scientific-symposium-2026-expands-focus-on-ophthalmic-imaging 2026-02-13 0.50 https://www.ophthalmologytimes.com/view/american-college-of-physicians-recommends-moving-away-from-provider-in-policy-paper 2026-02-10 0.50 https://www.ophthalmologytimes.com/view/floretina-2025-recap-the-art-of-retina-on-display-in-florence 2026-02-05 0.50 https://www.ophthalmologytimes.com/view/building-a-dry-eye-clinic-around-intense-pulsed-light-treatment 2026-02-05 0.50 https://www.ophthalmologytimes.com/view/optimising-ocular-surface-health-in-glaucoma-from-awareness-to-action 2026-02-06 0.50 https://www.ophthalmologytimes.com/view/broadening-horizons-expanding-your-surgical-portfolio-with-smile-pro-for-hyperopia 2026-02-01 0.50 https://www.ophthalmologytimes.com/view/igs-2026-clinical-pearls-for-detecting-pre-perimetric-glaucoma 2026-02-01 0.50 https://www.ophthalmologytimes.com/view/igs-2026-current-clinical-perspectives-on-optic-disc-drusen 2026-02-01 0.50 https://www.ophthalmologytimes.com/view/igs-2026-navigating-migs-and-other-modern-glaucoma-procedures 2026-01-31 0.50 https://www.ophthalmologytimes.com/view/igs-2026-the-expanding-role-of-artificial-intelligence-in-ophthalmology 2026-01-31 0.50 https://www.ophthalmologytimes.com/view/igs-2026-population-based-normative-data-could-transform-ai-in-glaucoma 2026-01-31 0.50 https://www.ophthalmologytimes.com/view/igs-2026-oct-in-neuro-ophthalmology-and-neurological-diseases 2026-01-31 0.50 https://www.ophthalmologytimes.com/view/study-finds-artificial-tear-viscosity-and-shear-thinning-behavior-vary-by-formulation 2026-01-30 0.50 https://www.ophthalmologytimes.com/view/international-glaucoma-symposium-aims-to-bridge-clinical-practice-and-emerging-technology 2026-01-30 0.50 https://www.ophthalmologytimes.com/view/phase-3-brio-trials-support-us-fda-approval-of-carbachol-brimonidine-eye-drop-for-presbyopia 2026-01-29 0.50 https://www.ophthalmologytimes.com/view/nanoscope-s-gene-therapy-mco-010-receives-sakigake-and-orphan-drug-designations-in-japan 2026-01-30 0.50 https://www.ophthalmologytimes.com/view/q-a-what-to-expect-from-the-2nd-international-glaucoma-symposium 2026-01-30 0.50 https://www.ophthalmologytimes.com/view/programme-preview-the-future-of-glaucoma-management-takes-shape-in-mainz-germany-conference 2026-01-30 0.50 https://www.ophthalmologytimes.com/view/uk-glaucoma-prevalence-nearly-50-higher-than-previously-estimated 2026-01-20 0.50 https://www.ophthalmologytimes.com/view/moorfields-launches-world-s-first-dedicated-hypotony-clinic 2026-01-12 0.50 https://www.ophthalmologytimes.com/view/orbital-and-retinal-microvascular-changes-in-thyroid-eye-disease 2026-01-08 0.50 https://www.ophthalmologytimes.com/view/long-lived-greenland-sharks-may-point-to-new-approaches-for-retinal-disease 2026-01-08 0.50 https://www.ophthalmologytimes.com/view/staar-surgical-terminates-proposed-acquisition-by-alcon 2026-01-07 0.50 https://www.ophthalmologytimes.com/view/international-meta-analysis-highlights-elevated-ocular-risk-in-clade-i-monkeypox 2026-01-06 0.50 https://www.ophthalmologytimes.com/view/recovery-of-cone-mediated-vision-in-teenagers-with-lca 2025-12-12 0.50 https://www.ophthalmologytimes.com/view/fda-crl-ons-5010-resubmitted-bla-outlook-therapeutics 2025-12-31 0.50 https://www.ophthalmologytimes.com/view/interventional-glaucoma-redefining-the-optometrist-s-role-in-modern-glaucoma-management 2025-12-12 0.50 https://www.ophthalmologytimes.com/view/the-endgame-of-inherited-retinal-disease-trials 2025-12-12 0.50 https://www.ophthalmologytimes.com/view/targeted-therapies-for-multifactorial-ocular-surface-disease 2025-12-12 0.50 https://www.ophthalmologytimes.com/view/floretina-inadvertent-anti-vegf-interval-increases-during-the-covid-19-pandemic 2025-12-18 0.50 https://www.ophthalmologytimes.com/view/domp-enrolls-first-patients-in-phase-3-trial-of-isocyclosporin-for-atopic-keratoconjunctivitis 2025-12-18 0.50 https://www.ophthalmologytimes.com/view/floretina-2025-ai-in-practice-discussed-by-marion-munk-and-quan-dong-nguyen 2025-12-15 0.50 https://www.ophthalmologytimes.com/view/floretina-2025-a-second-m-ller-glial-cell-type-in-the-human-fovea 2025-12-16 0.50 https://www.ophthalmologytimes.com/view/floretina-2025-real-world-aflibercept-data-supports-clinically-guided-flexible-namd-dosing 2025-12-19 0.50 https://www.ophthalmologytimes.com/view/tinlarebant-phase-3-dragon-study-for-adolescent-stargardt-disease 2025-12-11 0.50 https://www.ophthalmologytimes.com/view/floretina-2025-long-term-follow-up-in-paediatric-gene-therapy 2025-12-10 0.50 https://www.ophthalmologytimes.com/view/macular-laser-picks-up-speed-the-technology-accelerating-retinal-therapies 2025-12-04 0.50 https://www.ophthalmologytimes.com/view/floretina-2025-eu-rop-registry-real-world-insight 2025-12-09 0.50 https://www.ophthalmologytimes.com/view/floretina-2025-enrico-borrelli-retinal-disease-choroidal-health 2025-12-05 0.50 https://www.ophthalmologytimes.com/view/floretina-2025-new-horizons-research-risk-management-rop 2025-12-11 0.50 https://www.ophthalmologytimes.com/view/floretina-2025-antithrombotic-use-examined-in-wet-amd-submacular-hemorrhage 2025-12-06 0.50 https://www.ophthalmologytimes.com/view/floretina-2025-remotely-managing-patients-with-neovascular-age-related-macular-degeneration 2025-11-24 0.50 https://www.ophthalmologytimes.com/view/floretina-2025-navigating-antithrombotic-therapy-in-wet-amd 2025-11-26 0.50 https://www.ophthalmologytimes.com/view/floretina-2025-multimodal-deep-learning-for-ckd-diagnosis-using-retinal-images-and-urine-dipstick-data 2025-11-24 0.50 https://www.ophthalmologytimes.com/view/floretina-2025-rethinking-terson-syndrome-through-multimodal-imaging 2025-12-05 0.50 https://www.ophthalmologytimes.com/view/floretina-2025-bridging-global-gaps-in-rop-care 2025-12-04 0.50 https://www.ophthalmologytimes.com/view/floretina-2025-port-delivery-system-shows-reliable-6-month-durability-and-sustained-efficacy-in-neovascular-amd-for-up-to-7-years 2025-11-24 0.50 https://www.ophthalmologytimes.com/view/floretina-2025-fibrosis-a-limiting-factor-in-visual-acuity-outcomes-in-neovascular-amd 2025-11-24 0.50 https://www.ophthalmologytimes.com/view/floretina-2025-weight-and-pma-drive-foveal-maturation-in-preterm-infants 2025-11-26 0.50 https://www.ophthalmologytimes.com/view/floretina-2025-severity-of-ocular-injuries-resulting-from-water-jets-used-to-quell-riots 2025-11-26 0.50 https://www.ophthalmologytimes.com/view/floretina-2025-artificial-intelligence-at-frontlines-of-rop-care 2025-12-04 0.50 https://www.ophthalmologytimes.com/view/patent-granted-to-kiora-pharmaceuticals-kio-100-formulations 2025-12-02 0.50 https://www.ophthalmologytimes.com/view/celltrion-s-eylea-referencing-biosimilar-eydenzelt-receives-canadian-approval 2025-12-02 0.50 https://www.ophthalmologytimes.com/view/evolving-practice-in-retinal-care-a-question-of-control 2025-12-01 0.50 https://www.ophthalmologytimes.com/view/how-digital-workflow-boosted-my-confidence-and-elevated-premium-patient-rates-in-cataract-surgery 2026-01-20 0.50 https://www.ophthalmologytimes.com/view/from-skepticism-to-clarity-and-focus-a-family-s-presbyond-experience 2025-12-10 0.50 https://www.ophthalmologytimes.com/view/clinical-implications-of-demodex-blepharitis 2025-12-04 0.50 https://www.ophthalmologytimes.com/view/real-world-burden-of-demodex-blepharitis-in-the-uk 2025-12-04 0.50 https://www.ophthalmologytimes.com/view/floretina-2025-industry-advances-front-and-center-at-floretina-congress 2025-11-25 0.50 https://www.ophthalmologytimes.com/view/revisiting-an-overlooked-solution-for-high-myopia-aao-matteo-piovalla-phakic-iol 2025-11-21 0.50 https://www.ophthalmologytimes.com/view/floretina-congress-celebrates-10-years-with-joint-world-retinopathy-of-prematurity-meeting 2025-11-25 0.50 https://www.ophthalmologytimes.com/view/the-accessibility-barriers-still-hindering-ophthalmology 2025-11-21 0.50 https://www.ophthalmologytimes.com/view/the-continued-harm-of-cannula-dislodgement 2025-11-21 0.50 https://www.ophthalmologytimes.com/view/q-a-the-story-of-accommodation-and-the-rise-of-presbyopia-research 2025-11-11 0.50 https://www.ophthalmologytimes.com/view/q-a-katherine-talcott-on-the-advances-in-surgical-imaging-tools 2025-11-11 0.50 https://www.ophthalmologytimes.com/view/q-a-i-paul-singh-on-the-travoprost-intracameral-implant-in-conjunction-with-cataract-surgery 2025-11-11 0.50 https://www.ophthalmologytimes.com/view/q-a-david-eichenbaum-on-the-outcomes-of-the-aspire-phase-2b-trial 2025-11-11 0.50 https://www.ophthalmologytimes.com/view/q-a-advancements-in-laser-refractive-surgery 2025-11-06 0.50 https://www.ophthalmologytimes.com/view/q-a-jay-chhablani-discusses-analysis-of-retinal-vasculitis-events-with-intravitreal-agents 2025-11-07 0.50 https://www.ophthalmologytimes.com/view/q-a-margaret-chang-on-the-phase-1-trial-of-otx-tki-for-diabetic-retinopathy 2025-11-07 0.50 https://www.ophthalmologytimes.com/view/q-a-kenneth-fan-on-mco-010-trials-for-stargardt-disease 2025-11-06 0.50 https://www.ophthalmologytimes.com/view/q-a-arshad-khanani-discussed-the-open-label-extension-of-the-gather2-trial 2025-11-06 0.50 https://www.ophthalmologytimes.com/view/q-a-sharon-fekrat-discusses-retinal-manifestations-of-antipsychotic-medications 2025-11-06 0.50 https://www.ophthalmologytimes.com/view/q-a-stephen-tsang-discusses-outcomes-in-retinitis-pigmentosa-and-stargardt-trials 2025-12-01 0.50 https://www.ophthalmologytimes.com/view/q-a-diana-do-shares-real-world-insights-on-aflibercept-8-mg 2025-11-06 0.50 https://www.ophthalmologytimes.com/view/q-a-james-chelnis-discusses-aao-2025-presentation-on-aesthetic-facial-surgery 2025-11-05 0.50 https://www.ophthalmologytimes.com/view/q-a-rocha-shares-details-on-tolerance-of-astigmatism-with-fvr-iol 2025-11-07 0.50 https://www.ophthalmologytimes.com/view/nanoscope-therapeutics-releases-positive-long-term-extend-safety-data-in-retinitis-pigmentosa 2025-11-06 0.50 https://www.ophthalmologytimes.com/view/q-a-ashkan-abbey-shares-details-from-davio-2-trial-at-aao-2025 2025-11-05 0.50 https://www.ophthalmologytimes.com/view/eli-lilly-announces-acquisition-adverum-biotechnologies-gene-therapy-wet-amd 2025-11-04 0.50 https://www.ophthalmologytimes.com/view/topcon-healthcare-will-acquire-toku-inc-and-announces-investment-from-sanro-health 2025-11-03 0.50 https://www.ophthalmologytimes.com/view/sunir-j-garg-md-shares-non-infectious-endophthalmitis-insights-american-academy-ophthalmology-aao-2025 2025-10-30 0.50 https://www.ophthalmologytimes.com/view/sparingvision-dosing-patients-retinitis-pigmentosa-nyrvana-clinical-trial-spvn20-inherited-retinal-disease-gene-therapy 2025-10-29 0.50 https://www.ophthalmologytimes.com/view/optogenetics-for-retinal-disease-mutation-agnostic-gene-therapy-approach-offers-new-possibilities-for-patients-with-advanced-retinal-disease 2025-10-29 0.50 https://www.ophthalmologytimes.com/view/bascom-palmer-eye-institute-will-open-abu-dhabi-facility-in-november 2025-10-29 0.50 https://www.ophthalmologytimes.com/view/a-new-direction-for-therapeutic-keratopigmentation-cosmetic-iris-eye-colour-change 2025-10-28 0.50 https://www.ophthalmologytimes.com/view/celebrating-25-years-of-euretina-in-paris-france-european-society-retina-specialists-recap 2025-10-28 0.50 https://www.ophthalmologytimes.com/view/efficiency-in-glaucoma-practices-begins-with-an-intentional-design 2025-10-27 0.50 https://www.ophthalmologytimes.com/view/aao-2025-home-oct-provides-a-granular-look-at-retinal-pathologies 2025-10-24 0.50 https://www.ophthalmologytimes.com/view/sydnexis-syd-101-receives-us-fda-complete-response-letter-for-paediatric-myopia-treatment 2025-10-24 0.50 https://www.ophthalmologytimes.com/view/aao-2025-john-berdahl-md-on-different-lenses-to-consider-in-pseudoexfoliation 2025-10-19 0.50 https://www.ophthalmologytimes.com/view/aao-2025-inovations-in-glaucoma-laser-therapy 2025-10-23 0.50 https://www.ophthalmologytimes.com/view/aao-2025-an-early-adopter-of-the-leos-system-explains-its-benefits-in-the-operating-room 2025-10-21 0.50 https://www.ophthalmologytimes.com/view/us-fda-approves-epioxa-topical-treatment-for-keratoconus-care 2025-10-21 0.50 https://www.ophthalmologytimes.com/view/aao-2025-the-safety-and-efficacy-of-oral-gildeuretinol-in-participants-with-intermediate-stage-stargardt-disease 2025-10-21 0.50 https://www.ophthalmologytimes.com/view/aao-2025-discussing-the-48-month-results-from-oaks-derby-and-gale 2025-10-21 0.50 https://www.ophthalmologytimes.com/view/aao-2025-ken-beckman-discusses-trial-demonstrating-safety-and-efficacy-of-epithelium-on-cxl 2025-10-21 0.50 https://www.ophthalmologytimes.com/view/aao-2025-arshad-m-khanani-md-shares-ga-results-from-the-gather2-extension-trial 2025-10-21 0.50 https://www.ophthalmologytimes.com/view/aao-2025-prof-peter-stalmans-says-single-use-lenses-are-better-for-patients 2025-10-21 0.50 https://www.ophthalmologytimes.com/view/durga-borkar-md-on-avacincaptad-pegol-as-routine-care-for-geographic-atrophy-aao-2025-american-academy-ophthalmology 2025-10-23 0.50 https://www.ophthalmologytimes.com/view/aao-2025-subretinal-drusenoid-deposits-in-black-and-hispanic-patients-with-amd 2025-10-16 0.50 https://www.ophthalmologytimes.com/view/aao-2025-jean-francois-korobelnik-md-shares-highlights-from-the-pulsar-extension-study 2025-10-15 0.50 https://www.ophthalmologytimes.com/view/prevalence-of-demodex-blepharitis-in-japan-and-europe 2025-10-17 0.50 https://www.ophthalmologytimes.com/view/aao-debuts-technician-training-platform-ahead-of-2025-meeting-collaboration-american-academy-ophthalmology-alchemy-vision 2025-10-15 0.50 https://www.ophthalmologytimes.com/view/biotech-healthcare-launches-optiflex-xtense-comfort-plus-edof-iol 2025-10-15 0.50 https://www.ophthalmologytimes.com/view/research-describes-a-novel-biomarker-of-tissue-hypoxia-in-pdr-and-rvo 2025-10-13 0.50 https://www.ophthalmologytimes.com/view/euretina-2025-jay-chhablani-md-provides-an-update-on-gene-therapy-for-amd-and-ga 2025-10-09 0.50 https://www.ophthalmologytimes.com/view/what-to-expect-at-the-american-academy-of-ophthalmology-meeting-aao-2025-imagine 2025-10-08 0.50 https://www.ophthalmologytimes.com/view/do-cosmetic-contact-lenses-have-a-lower-microbial-keratitis-rate-than-keratopigmentation- 2025-10-08 0.50 https://www.ophthalmologytimes.com/view/insights-into-atropine-usage-long-term-complications-red-light-therapy-paediatric-children 2025-10-06 0.50 https://www.ophthalmologytimes.com/view/broader-perspective-for-the-treatment-approach-retinal-neovascular-diseases-biomarkers-staging 2025-10-06 0.50 https://www.ophthalmologytimes.com/view/aao-2025-the-eye-care-network-s-clinical-advisors-presentation-round-up 2025-10-02 0.50 https://www.ophthalmologytimes.com/view/complex-glaucoma-management-from-anterior-to-posterior-segment 2025-10-01 0.50 https://www.ophthalmologytimes.com/view/intravitreal-complement-inhibitor-treatment-for-geographic-atrophy-ga-viewed-favorably-by-patients 2025-09-30 0.50 https://www.ophthalmologytimes.com/view/editorial-advisory-board-member-alexandra-miere-md-phd-presents-two-studies-at-euretina 2025-09-30 0.50 https://www.ophthalmologytimes.com/view/euretina-2025-this-international-symposium-vit-buckle-society-vbs-started-as-a-students-dinner-club 2025-09-29 0.50 https://www.ophthalmologytimes.com/view/nhs-tayside-streamlines-uk-cataract-surgeries-with-lutra-health-optometry-dundee-scotland 2025-09-26 0.50 https://www.ophthalmologytimes.com/view/mario-romano-md-phd-stresses-the-importance-of-thermodynamic-control-in-vitrectomy 2025-09-25 0.50 https://www.ophthalmologytimes.com/view/advances-in-the-diagnosis-and-treatment-of-demodex-blepharitis 2025-09-25 0.50 https://www.ophthalmologytimes.com/view/eyenuk-deploys-autonomous-ai-eye-screening-technology-throughout-norway 2025-09-25 0.50 https://www.ophthalmologytimes.com/view/macumira-launches-first-health-canada-approved-device-for-amd-treatment 2025-09-23 0.50 https://www.ophthalmologytimes.com/view/mark-gillies-md-phd-introduces-the-next-generation-of-anti-vegf-agents-euretina-age-related-macular-degeneration 2025-10-09 0.50 https://www.ophthalmologytimes.com/view/euretina-2025-diabetic-eye-disease-needs-a-new-staging-system 2025-09-19 0.50 https://www.ophthalmologytimes.com/view/camiel-boon-md-phd-netherlands-euretina-febo-explores-the-mysteries-of-central-serous-chorioretinopathy 2025-09-19 0.50 https://www.ophthalmologytimes.com/view/european-commission-grants-marketing-authorisation-to-aflibercept-biosimilar-eyluxvi-alt-l9-alteogen-eylea 2025-09-17 0.50 https://www.ophthalmologytimes.com/view/euretina-oct-a-optical-coherence-tomography-andreas-pollreisz-angiography-retina 2025-09-12 0.50 https://www.ophthalmologytimes.com/view/heidelberg-staar-ziemer-showcase-latest-technologies-cataract-refractive-escrs-2025 2025-09-25 0.50 https://www.ophthalmologytimes.com/view/exploring-the-ai-digital-artificial-intelligence-workflow-with-harvey-uy-md-dpbo-fvrsp-at-euretina-2025 2025-09-12 0.50 https://www.ophthalmologytimes.com/view/new-technologies-to-be-showcased-by-bvi-virtualens-at-escrs-2025 2025-09-10 0.50 https://www.ophthalmologytimes.com/view/upcoming-company-presentations-from-alcon-j-j-b-l-at-escrs-2025 2025-09-10 0.50 https://www.ophthalmologytimes.com/view/ciliatech-leadership-comments-on-ce-mark-for-novel-glaucoma-device-escrs-2025-inovation-announcement 2025-09-09 0.50 https://www.ophthalmologytimes.com/view/euretina-2025-boris-stanzel-md-methotrexate-retinal-detachment-pvr-microperimetry-oedema-geographic-atrophy 2025-09-10 0.50 https://www.ophthalmologytimes.com/view/euretina-2025-marion-munk-md-phd-discusses-the-intris-symposium 2025-09-16 0.50 https://www.ophthalmologytimes.com/view/euretina-2025-aleksandra-rachitskaya-and-danilo-iannetta-on-the-vit-buckle-symposium 2025-09-06 0.50 https://www.ophthalmologytimes.com/view/euretina-leadership-welcome-record-breaking-number-of-attendees 2025-09-05 0.50 https://www.ophthalmologytimes.com/view/euretina-grants-prithvi-ramtohul-md-2025-ramin-tadayoni-award-winner-grant-funding 2025-09-04 0.50 https://www.ophthalmologytimes.com/view/ema-grants-orphan-designations-to-mco-010-across-5-categories-of-retinal-dystrophies 2025-09-03 0.50 https://www.ophthalmologytimes.com/view/euretina-industry-previews-beacon-therapeutics-nanoscope-therapeutics-valitor-2025-presentations 2025-08-29 0.50 https://www.ophthalmologytimes.com/view/navigating-the-dangers-of-oculofacial-surgery-egyptian-ophthalmological-society-keynote-tao 2025-08-29 0.50 https://www.ophthalmologytimes.com/view/ashvattha-therapeutics-clearside-biomedical-zeiss-industry-preview-euretina-presentations-new-clinical-trial-data 2025-08-28 0.50 https://www.ophthalmologytimes.com/view/progression-rates-subtypes-geographic-atrophy-lesions-growth-age-related-macular-degeneration 2025-08-27 0.50 https://www.ophthalmologytimes.com/view/eye-care-network-modern-retina-editorial-board-2025-euretina-congress-paris 2025-08-26 0.50 https://www.ophthalmologytimes.com/view/faq-questions-answered-euretina-25th-annual-congress-european-society-retina-specialists-paris-france-2025 2025-08-26 0.50 https://www.ophthalmologytimes.com/view/keys-to-optimising-phaco-efficiency-refractive-surgery-cataract-planning 2025-08-20 0.50 https://www.ophthalmologytimes.com/view/european-commission-issues-ce-mark-for-zeiss-cirrus-pathfinder-ai-tool 2025-08-21 0.50 https://www.ophthalmologytimes.com/view/green-spaces-nature-protect-against-dry-eye-disease-urban-eye-health 2025-08-20 0.50 https://www.ophthalmologytimes.com/view/neovascular-age-related-macular-degeneration-gene-therapy-controversy-future-efficacy-invasive 2025-08-19 0.50 https://www.ophthalmologytimes.com/view/qu-bec-announces-faricimab-injection-vabysmo-roche-will-be-funded-for-macular-oedema-secondary-to-rvo 2025-08-19 0.50 https://www.ophthalmologytimes.com/view/from-optical-to-digital-precision-advancing-retinal-surgery-with-the-artevo-850-microscope 2026-01-15 0.50 https://www.ophthalmologytimes.com/view/first-clinical-results-demonstrate-efficacy-of-voy-101-a-novel-gene-therapy-for-geographic-atrophy-asrs-omer-trivizki 2025-08-18 0.50 https://www.ophthalmologytimes.com/view/clinicians-keep-their-eyes-on-wartime-ocular-trauma-ukraine-surgery 2025-09-02 0.50 https://www.ophthalmologytimes.com/view/patient-outcomes-retinoblastoma-parents-intervention-delays-treatment-diagnosis-blindness-survival 2025-08-14 0.50 https://www.ophthalmologytimes.com/view/early-experience-of-aflibercept-8mg-eylea-8mg-in-routine-clinical-practice 2025-08-14 0.50 https://www.ophthalmologytimes.com/view/the-future-of-imaging-recap-heidelberg-iss-international-spectralis-symposium 2025-08-13 0.50 https://www.ophthalmologytimes.com/view/australian-biotech-firm-mirugen-secures-major-funding-for-cell-reprogramming-therapy-retina-retinitis-pigmentosa-stargardt-amd 2025-08-13 0.50 https://www.ophthalmologytimes.com/view/eyeing-the-brain-how-ocular-mitochondrial-disease-may-predict-dementia-risk 2025-08-13 0.50 https://www.ophthalmologytimes.com/view/sandoz-license-lupin-ranibizumab-lucentis-biosimilar-europe-asia-emea-lubt010 2025-08-12 0.50 https://www.ophthalmologytimes.com/view/german-case-study-illustrates-systemic-presentation-of-tubulointerstitial-nephritis-and-uveitis-paediatric-teenager 2025-08-11 0.50 https://www.ophthalmologytimes.com/view/helping-patients-navigate-the-unsolved-mysteries-of-genetic-testing 2025-08-11 0.50